Librum Network
Menu
j

james-sterling27librumnetwork-com

Content creator and writer. Sharing insights and expertise on topics that matter.

Articles by james-sterling27librumnetwork-com

Latest Posts

Africrypt Founders Raees and Ameer Cajee Back in South Africa After Years on the Run
Business

Africrypt Founders Raees and Ameer Cajee Back in South Africa After Years on the Run

The notorious South African duo known as the “Bitcoin Brothers,” Raees and Ameer Cajee, have reportedly made a discreet return

Read
2 Top Dividend Growth Stocks for 10-Year Hold
Investing

2 Top Dividend Growth Stocks for 10-Year Hold

Two standout dividend-paying stocks possess powerful long-term growth drivers and impressive dividend expansion rates that are likely to captivate investors

Read
Food & Drink Giants Reinvent Brands Amid Challenges
Business

Food & Drink Giants Reinvent Brands Amid Challenges

For many years, the worldwide branded food and beverage industry has been a top pick for cautious investors seeking stability.

Read
Billionaires Bail Out Rural America, Not Trump
Business

Billionaires Bail Out Rural America, Not Trump

Communities across rural America are receiving substantial financial support. This assistance is not originating from political figures like Trump. Instead,

Read
Black Swift Group Sells 3,405 MercadoLibre Shares for $8M
Investing

Black Swift Group Sells 3,405 MercadoLibre Shares for $8M

Key Points Black Swift Group, LLC completely divested its holdings in MercadoLibre by selling 3,405 shares during the fourth quarter.

Read
3 Tax-Saving Secrets of the Ultrawealthy, Including Strategic Estate Planning
Personal Finance

3 Tax-Saving Secrets of the Ultrawealthy, Including Strategic Estate Planning

Death and taxes are unavoidable realities in life, but leaving a hefty tax burden on your heirs is entirely preventable.

Read
Halozyme Therapeutics Q4 2025 Earnings Presentation
Business

Halozyme Therapeutics Q4 2025 Earnings Presentation

Halozyme Therapeutics, Inc. Q4 2025 Earnings Call Slide Deck Halozyme Therapeutics, Inc. (NASDAQ: HALO) recently conducted its fourth quarter earnings

Read
Palantir Faces AI Disruption Risks
Investing

Palantir Faces AI Disruption Risks

Palantir’s Recent Decline Amid AI Concerns Palantir Technologies has experienced a significant drop in its stock value, primarily because investors

Read
Board Directors Emerge as Top CEO Contenders in Firms
Business

Board Directors Emerge as Top CEO Contenders in Firms

Selecting board members to serve as chief executive officers was historically viewed as an extreme measure, akin to breaking glass

Read